ATM Suppresses SATB1-Induced Malignant Progression in Breast Epithelial Cells

SATB1 drives metastasis when expressed in breast tumor cells by radically reprogramming gene expression. Here, we show that SATB1 also has an oncogenic activity to transform certain non-malignant breast epithelial cell lines. We studied the non-malignant MCF10A cell line, which is used widely in the literature. We obtained aliquots from two different sources (here we refer to them as MCF10A-1 and MCF10A-2), but found them to be surprisingly dissimilar in their responses to oncogenic activity of SATB1. Ectopic expression of SATB1 in MCF10A-1 induced tumor-like morphology in three-dimensional cultures, led to tumor formation in immunocompromised mice, and when injected into tail veins, led to lung metastasis. The number of metastases correlated positively with the level of SATB1 expression. In contrast, SATB1 expression in MCF10A-2 did not lead to any of these outcomes. Yet DNA copy-number analysis revealed that MCF10A-1 is indistinguishable genetically from MCF10A-2. However, gene expression profiling analysis revealed that these cell lines have significantly divergent signatures for the expression of genes involved in oncogenesis, including cell cycle regulation and signal transduction. Above all, the early DNA damage-response kinase, ATM, was greatly reduced in MCF10A-1 cells compared to MCF10A-2 cells. We found the reason for reduction to be phenotypic drift due to long-term cultivation of MCF10A. ATM knockdown in MCF10A-2 and two other non-malignant breast epithelial cell lines, 184A1 and 184B4, enabled SATB1 to induce malignant phenotypes similar to that observed for MCF10A-1. These data indicate a novel role for ATM as a suppressor of SATB1-induced malignancy in breast epithelial cells, but also raise a cautionary note that phenotypic drift could lead to dramatically different functional outcomes.

[1]  Beyer,et al.  FOXP 3 and FOXP 3-regulated microRNAs suppress the expression of SATB 1 in breast cancer cell lines , 2014 .

[2]  Y. Kohwi,et al.  Genome organizing function of SATB1 in tumor progression. , 2013, Seminars in cancer biology.

[3]  G. Goodall,et al.  FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells , 2012, Oncogene.

[4]  W. Han,et al.  BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation. , 2012, Developmental cell.

[5]  J. Fitzpatrick,et al.  A Telomere Dependent DNA Damage Checkpoint Induced by Prolonged Mitotic Arrest , 2012, Nature Structural &Molecular Biology.

[6]  Stephen T. C. Wong,et al.  Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. , 2011, Molecular cell.

[7]  Young Jae Woo,et al.  Satb1 Ablation Alters Temporal Expression of Immediate Early Genes and Reduces Dendritic Spine Density during Postnatal Brain Development , 2011, Molecular and Cellular Biology.

[8]  H. Uchi,et al.  Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. , 2011, Journal of dermatological science.

[9]  C. Missero,et al.  p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis , 2011, The Journal of cell biology.

[10]  T. Karn,et al.  SATB1 gene expression and breast cancer prognosis. , 2011, Breast.

[11]  S. Galande,et al.  Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. , 2011, Oligonucleotides.

[12]  Xi-xi Cao,et al.  Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells , 2011, Cell Death and Differentiation.

[13]  X. Lu,et al.  Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  M. Lippman,et al.  The role of SATB1 in breast cancer pathogenesis. , 2010, Journal of the National Cancer Institute.

[15]  Jon C. Aster,et al.  Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells , 2010, Proceedings of the National Academy of Sciences.

[16]  F. Béna,et al.  Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells* , 2010, Journal of Biological Chemistry.

[17]  Mitsutaka Kadota,et al.  Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines , 2010, PloS one.

[18]  Qing-quan Li,et al.  Overexpression and involvement of special AT‐rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells , 2010, Cancer science.

[19]  S. Galande,et al.  Global Regulator SATB1 Recruits β-Catenin and Regulates TH2 Differentiation in Wnt-Dependent Manner , 2010, PLoS biology.

[20]  Q. Tong,et al.  SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. , 2010, Oncology reports.

[21]  R. Mansel,et al.  The mRNA expression of SATB1 and SATB2 in human breast cancer , 2009, Cancer Cell International.

[22]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[23]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[24]  L. Kenner,et al.  SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. , 2009, Developmental cell.

[25]  A. Imbalzano,et al.  Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture , 2009, Cancer Cell International.

[26]  Ashok R Venkitaraman,et al.  Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. , 2009, Annual review of pathology.

[27]  Anastasia Khvorova,et al.  Identification of genes that regulate epithelial cell migration using an siRNA screening approach , 2008, Nature Cell Biology.

[28]  J. Russo,et al.  SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis , 2008, Nature.

[29]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[30]  P. Steeg,et al.  Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.

[31]  Kornelia Polyak,et al.  Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.

[32]  R. Bjerkvig,et al.  Cancer initiation and progression: involvement of stem cells and the microenvironment. , 2007, Biochimica et biophysica acta.

[33]  Qi Dai,et al.  Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival , 2007, Cancer.

[34]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[35]  E. Fanning,et al.  RPA2 Is a Direct Downstream Target for ATR to Regulate the S-phase Checkpoint* , 2006, Journal of Biological Chemistry.

[36]  Cancer: the prognosis , 2006, Nature.

[37]  A. Fischer,et al.  The ultrastructure of MCF‐10A acini , 2006, Journal of cellular physiology.

[38]  T. Kohwi-Shigematsu,et al.  SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes , 2006, Nature Genetics.

[39]  Jayanta Debnath,et al.  Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.

[40]  D. Cortez.  Unwind and slow down: checkpoint activation by helicase and polymerase uncoupling. , 2005, Genes & development.

[41]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[42]  J. Cedarbaum.  Survival , 2004 .

[43]  Y. Yarden,et al.  Oncogenic growth factor receptors: implications for signal transduction therapy. , 2004, Seminars in cancer biology.

[44]  Fred R. Miller,et al.  Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.

[45]  Jingwen Liu,et al.  Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1 , 2003, Oncogene.

[46]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[47]  T. Kohwi-Shigematsu,et al.  Tissue-specific nuclear architecture and gene expession regulated by SATB1 , 2003, Nature Genetics.

[48]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[49]  T. Kohwi-Shigematsu,et al.  SATB1 targets chromatin remodelling to regulate genes over long distances , 2002, Nature.

[50]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[51]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[52]  D. Durocher,et al.  DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? , 2001, Current opinion in cell biology.

[53]  F. Miller,et al.  Nontransgenic models of breast cancer. , 2000, Breast cancer research : BCR.

[54]  J. Trojanowski,et al.  Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary , 2000, Cancer.

[55]  H. Niida,et al.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. , 2000, Genes & development.

[56]  P. Yaswen,et al.  Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. , 1997, Molecular biology of the cell.

[57]  F. Miller,et al.  Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines. , 1997, Anticancer research.

[58]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[59]  G. Xiao,et al.  Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. , 1997, Cancer research.

[60]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[61]  Y. Shiloh,et al.  The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.

[62]  F. Miller,et al.  MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.

[63]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .

[64]  E K Rowinsky,et al.  Paclitaxel (taxol) , 1995, The New England journal of medicine.

[65]  R. Metcalf,et al.  p53 mutations in human immortalized epithelial cell lines. , 1993, Carcinogenesis.

[66]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Y. Kohwi,et al.  A tissue-specific MAR SAR DNA-binding protein with unusual binding site recognition , 1992, Cell.

[68]  H. Soule,et al.  Characterization of epithelial phenotypes in mortal and immortal human breast cells , 1992, International journal of cancer.

[69]  J. Bode,et al.  Biological significance of unwinding capability of nuclear matrix-associating DNAs. , 1992, Science.

[70]  Y. Kohwi,et al.  Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer. , 1990, Biochemistry.

[71]  J. Russo,et al.  Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[72]  J. Russo,et al.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[73]  M. Stampfer,et al.  Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. , 1989, Cancer genetics and cytogenetics.

[74]  M. Bissell.  The differentiated state of normal and malignant cells or how to define a "normal" cell in culture. , 1981, International review of cytology.